Predictive Oncology (POAI)

• Market cap: $7.08M
• 1 day: -1.38%
• 5 days: -27.54%
• 1 month: -47.07%
• 3 months: -20.19%
• 6 months: -30.57%
• Year to date: -32.68%
• 1 year: -4.72%
• 5 years: -96.3%
• 10 years: -100%
• Sector: Healthcare
• Industry: Health Information Services

About: Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Employees: 24